Studies have shown that KBI-092 exhibits potent inhibitory activity against this protein, with an IC50 value of <10 nM. This high level of potency and selectivity makes KBI-092 an attractive therapeutic candidate for the treatment of inflammatory diseases.
The mechanism of action of KBI-092 involves the inhibition of a specific protein-protein interaction that is crucial for the activation of inflammatory cells. By blocking this interaction, KBI-092 prevents the activation of downstream signaling pathways that lead to the production of pro-inflammatory cytokines and chemokines. KBI-092
KBI-092 works by selectively inhibiting this protein, thereby reducing the production of pro-inflammatory mediators and modulating the immune response. This results in a decrease in inflammation and tissue damage, providing relief for patients suffering from inflammatory diseases. Studies have shown that KBI-092 exhibits potent inhibitory